Dextrose Side Effects
How can Dextrose Side Effects affect You? | PatientsVille.com
View and Submit Dextrose Side Effects
Your Dextrose Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
DEXTRAN 4 SODIUM LA
Active Ingredient: ADENINE; ANHYDROUS CALCIUM C DEXTRAN 4 DEXTROSE DEXTROSE;
Side Effects reported to FDA: 166. View Dextrose Adverse Reports
Reported deaths: 8
Reported hospitalizations: 31
Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility
AUDIENCE: Pharmacy, Patient, Health Professional
ISSUE: Hospira, Inc. is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, NDC 0409-7929-09. This action is due to one confirmed customer report where a spore-like structured particulate, consistent with mold, was noted in the solution. Hospira has not received reports of any adverse events associated with this issue for this lot, and has not identified any quality issues with retention samples for this lot. If contaminated solution is used on a patient, this may cause thrombosis, phlebitis, bacteremia, sepsis, septic shock and/or endocarditis, or result in a fatal infection in a broad array of patients.
BACKGROUND: The product is used as a source of water, electrolytes and calories or as an alkalizing agent and is packaged in a 1000 mL flexible container, lot number 05-019-JT, with an expiration date of May 1, 2013. The affected lot was distributed nationwide between June 2011 and January 2012 to wholesalers/distributors, hospitals and pharmacies.
RECOMMENDATION: Anyone with an existing inventory should stop use and distribution, quarantine the product immediately, and call Stericycle at 1-888-965-5798 between the hours of 8am to 5pm EST, Monday through Friday, to arrange for the return of the product. Replacement product from other lots is available. For medical inquiries, please contact Hospira Medical Communications at 1-800-615-0187.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
[01/25/2013 - Firm Press Release - Hospira, Inc]
Dextrose Adverse Reactions
Pyrexia ( 28 Reports)|Chills ( 20 Reports)|Tremor ( 18 Reports)|Death ( 13 Reports)|Hypotension ( 13 Reports)|Anaphylactic Reaction ( 10 Reports)|Hyponatraemia ( 8 Reports)|C-reactive Protein Increased ( 7 Reports)|Convulsion ( 7 Reports)|Nausea ( 7 Reports)|Vomiting ( 7 Reports)|Back Pain ( 6 Reports)|Chest Pain ( 6 Reports)|Dizziness ( 6 Reports)|Dyspnoea ( 6 Reports)|Thrombocytopenia ( 6 Reports)|Activated Partial Thromboplastin Time Prolonged ( 5 Reports)|Bradycardia ( 5 Reports)|Extravasation ( 5 Reports)|Grand Mal Convulsion ( 5 Reports)|Infusion Related Reaction ( 5 Reports)|Blood Glucose Decreased ( 4 Reports)|Blood Glucose Increased ( 4 Reports)|Blood Pressure Increased ( 4 Reports)|Cardio-respiratory Arrest ( 4 Reports)|Dyskinesia ( 4 Reports)|Fatigue ( 4 Reports)|Haemoglobin Decreased ( 4 Reports)|Heart Rate Increased ( 4 Reports)|Hypoglycaemia ( 4 Reports)|